Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors Within the IMAGIO Project (A-IMAGIO)

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The endpoint of this study is to develop and validate algorithms, using artificial intelligence and machine learning, to optimize patient selection, treatment planning, treatment evaluation and outcome prediction in patients undergoing thermal ablation of a malignant liver tumor. The long-term objective is to establish thermal ablation as the treatment of choice for the vast majority of patients with a primary or secondary liver tumor by development of an accessible workflow that can be widely implemented in different centers performing thermal ablation. Over a time span of at least four years, data will be collected prospectively, encompassing patient information, tumor characteristics, and treatment details. Additionally, pre-, intra-, and post-procedural imaging will be systematically gathered.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 110
Healthy Volunteers: f
View:

• 18 years or above

• Candidate for percutaneous thermal liver ablation as discussed in a multidisciplinary tumorboard (MDT)

• Informed consent

Locations
Other Locations
Netherlands
Leiden University Medical Centre
RECRUITING
Leiden
Contact Information
Primary
Coosje A. M. Verhagen, Drs.
c.a.m.verhagen@lumc.nl
+31-71-5264376
Backup
Ariadne L. Velden, van der, Drs.
lisa.van.der.velden@mumc.nl
+31(0)43-3876910
Time Frame
Start Date: 2024-01-01
Estimated Completion Date: 2028-01-01
Participants
Target number of participants: 1500
Related Therapeutic Areas
Sponsors
Collaborators: Philips Healthcare, European Commission
Leads: Leiden University Medical Center

This content was sourced from clinicaltrials.gov